As there are not many studies examining the role of CD44, MMP-2, and MMP-9 in the carcinogenesis of RCC, especially in non-ccRCC, further research in a large cohort of patients is needed to understand the mechanism of RCC tumorigenesis and develop therapeutic stratification. The gene discussed is MMP9; the disease is renal cell carcinoma.